FdaApplication
BLA 761170
Identifiers
- fda_app_no: BLA761170
Properties
| Property | Value |
|---|---|
| applicant_name | Genentech, Inc. |
| application_type | BLA |
| approval_date | 2020-06-29 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| PHESGO | PERTUZUMAB, TRASTUZUMAB, AND HYALURONIDASE-ZZXF | 1,200MG | Injection |
| PHESGO | PERTUZUMAB, TRASTUZUMAB, AND HYALURONIDASE-ZZXF | 600MG | Injection |
2 products